Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMPHOTERICIN B vs AMPRENAVIR: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMPHOTERICIN B vs AMPRENAVIR: Safety Overview

Metric AMPHOTERICIN B AMPRENAVIR
Total FAERS Reports 10,797 109
Deaths Reported 4,777 4
Death Rate 44.2% 3.7%
Hospitalizations 3,790 16
Average Patient Age 44.4 yrs 44.0 yrs
% Female Patients 40.8% 25.0%
FDA Approval Date Approved Prior to Jan 1, 1982 Apr 15, 1999
Manufacturer Sun Pharmaceutical Industries, Inc. N/A
Route INTRAVENOUS N/A
Marketing Status Discontinued Discontinued